|
|
The randomized controlled study of acupotomy in treating cervical spinal hypertension |
WANG Likang CUI Binchuan WU Zhaofeng LI Zhanwu▲ |
Department of Pain, General Hospital of Armed Police Forces, Beijing 100039, China |
|
|
Abstract Objective To observe the clinical efficacy of acupotomy in treating cervical spinal hypertension, and to investigate the pathogenesis of it. Methods Sixty-two cases of patients diagnosed as cervical hypertension in General Hospital of Armed Police Forces from February 2014 to December 2016 were collected and divided into two groups in accordance with the random number table, each group had 31 cases. The experimental group was treated with the acupotomy therapy every three days, 2 times a week, for 8 times. The control group was treated with acupuncture, once a day, 7 times were as a course, total for 4 courses. The changes of blood pressure of the two groups before and after treatment were observed, and the clinical efficacy of the two groups was evaluated. Results There were no significant differences of systolic and diastolic blood pressure between the two groups before treatment (P > 0.05). The systolic blood pressure and diastolic blood pressure in the two groups after treatment were significantly lower than those before treatment (P < 0.01), and the systolic blood pressure and diastolic blood pressure in the experimental group were significantly lower than those in the control group (P < 0.01). The total effective rate of the experimental group was higher than that of the control group, the difference was statistically significant (P < 0.05). Conclusion The treatment of cervical hypertensive disease by manipulation with acupotomy for cervical soft tissue can significantly release the blood pressure and cervical symptoms, the curative effect is definite.
|
|
|
|
|
[1] 叶利斌,卢婷婷,吴汉元.颈源性高血压的临床研究新进展[J].中国全科医学,2013,16(9):3146.
[2] 张天民,龚重九.针刀整体松解术治疗颈性高血压病的机制探讨与临床研究[J].针灸临床杂志,2014,30(12):40.
[3] 中国高血压防治指南修订委员会.中国高血压防治指南2010[J].中华高血压杂志,2011,19(8):701-743.
[4] 国家中医药管理局.中医病证诊断疗效标准[S].南京:南京大学出版社,1994.
[5] 孙传兴.临床疾病诊断依据治愈好转标准[M].2版.北京:人民军医出版社,1998:511-512.
[6] 傅世英.高血压病防治的新进展[J].黑龙江医学,2004, 28(1):1-3.
[7] 刘瑛,赵子彦,赵生法,等.城市老年人高血压相关危险因素分析[J].中国现代医生,2007,45(8):18-19.
[8] 郭丰义,谢洪美,沈玉莲.高血压基因研究进展[J].中国医药导报,2006,5(3):21-22.
[9] 杨国红,周欣.高血压发病机制的基因学研究进展[J].武警医学,2013,24(11):985.
[10] 文佳,李莹,袁洪.关注高血压影响因素,选择合理治疗方案[J].中国全科医学,2015,18(8):861.
[11] 中国高血压防治指南修订委员会.中国高血压防治指南[J].中华心血管病杂志,2011,39(7):582.
[12] 陈海东,庞玉娜,洪小茜.高血压4种治疗方案的成本-效果分析[J].武警医学,2011,22(12):1056.
[13] 高树中,杨骏.针灸治疗学[M].北京:中国中医药出版社,2012:48.
[14] 曹玲,王顺.针刺颈部夹脊穴对颈源性高血压患者血浆内皮素影响的观察[J].针灸临床杂志,2007,23(7):9-10.
[15] Shapiro DA,Rcncoek S,Arrington E,et al. Aripiprazole,a novel atypical antipsychotic drug with a unique and robust pharmacology [J]. Neuropsychopharmacoligy,2003, 28(8):1401-1411.
[16] 赖春柏,段俊峰. 颈源性高血压实验研究进展[J].颈腰痛杂志,2009,30(1):75-77.
[17] 杨彬,何宗宝.颈上神经节与颈源性高血压的研究进展[J].中华高血压杂志,2014,22(2):129-131.
[18] Fonamw CC,Yancy CW,Hywood JT. Adherence to heart failure quality-of-care indicator in US hospitals:analysis of the ADHERE Registry [J]. Arch Intern Med,2005, 165(13):1469-1477.
[19] Zile MR,Brutsaert DL. New concepts in diastolic dysfunction and diastolic heart failure:Part Ⅱ:causal mechanisms and treatment [J]. Circulation,2002,105(12):1503-1508.
[20] 王芳,金宏柱.颈椎病致血压异常的中医治疗机制探讨[J].甘肃中医学院学报,2008,25(2):55-56.
[21] 彭杰.针刀为主治疗颈性高血压39例[J].针灸临床杂志,2005,21(9):28. |
|
|
|